Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China

Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China

AbstractBackground Cyclophosphamide (CTX) and calcineurin inhibitors (CNIs) based regimens are recommended as immunosuppressive therapies for patients with idiopathic membranous nephropathy (IMN). Focal and segmental glomerular sclerosis (FSGS) lesions, which are common in membranous nephropathy (MN...

Full description

Bibliographic Details
Main Authors:	Hong-Guang He, Yi-Yun Huang, Qin-Qing Liang, Qiu-Rong Ye, An-Dong Li, Kun Ye, Qiu-Xia Wu, Yan-Wu You
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Renal Failure
Subjects:	Membranous nephropathy cyclophosphamide calcineurin inhibitors focal and segmental glomerular sclerosis prognosis
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2023.2253930

Similar Items

Cyclophosphamide in the treatment of focal segmental glomerulosclerosis
by: R. Martinelli, et al.
Published: (2004-09-01)

Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression
by: Jaime M. Restrepo, et al.
Published: (2022-04-01)

Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases
by: Hong-Guang He, et al.
Published: (2019-08-01)

Non-immunologic Actions of Calcineurin Inhibitors (CNIs) in Proteinuric Kidney Diseases
by: Robert Frank Spurney
Published: (2014-11-01)

Membranous nephropathy
by: Márcio Dantas, et al.
Published: (2023-07-01)

Comparative proteomic analysis of children FSGS FFPE tissues
by: Jiajia Ni, et al.
Published: (2022-12-01)

Anuria after kidney transplantation diagnosed as early recurrence of focal segmental glomerulosclerosis combined with acute calcineurin inhibitor nephrotoxicity: a case report and literature review
by: Yoon-Ju Kim, et al.
Published: (2024-04-01)

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody
by: Wenkai Guo, et al.
Published: (2020-02-01)

Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
by: Cheng Xue, et al.
Published: (2023-09-01)

Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice
by: Constantinos Deltas, et al.
Published: (2023-08-01)

Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis
by: Masoud Etemadifar, et al.
Published: (2020-02-01)

Efficacy and safety of high-dose cyclophosphamide intravenous boost combined with glucocorticoid in treatment of idiopathic membranous nephropathy
by: XIE Xinfu, et al.
Published: (2021-06-01)

The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis
by: Ibrahim Batal, et al.
Published: (2023-02-01)

Challenging diagnosis of Kimura disease in a child with nephrotic syndrome: A case report
by: Roya Hemayati, et al.
Published: (2023-03-01)

Progression of diabetic nephropathy after successful pancreas transplantation alone: a case report
by: Yoonhong Kim, et al.
Published: (2019-12-01)

Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab
by: Karasavvidou Foteini, et al.
Published: (2011-07-01)

Response to immunosuppressive therapy in PLA2R- associated and non-PLA2R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study
by: Jia Wang, et al.
Published: (2017-07-01)

Clinicopathological Analysis of Biopsy-Proven Glomerulonephritis in the Pediatric Patients : A Study from Tertiary Care Centre
by: Rabia Saleem Safdar, et al.
Published: (2022-10-01)

CUBN gene mutations may cause focal segmental glomerulosclerosis (FSGS) in children
by: Jing Yang, et al.
Published: (2022-01-01)

The Efficacy of Cyclophosphamide Combined with Prednisone in Membranous Nephropathy Patients with Different Cytochrome P450 2B6 Gene Polymorphisms and Analysis of Factors Influencing the Efficacy
by: Zhang M, et al.
Published: (2022-10-01)

Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study
by: Shasha Chen, et al.
Published: (2020-02-01)

Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide
by: Raja Ramachandran, et al.
Published: (2017-07-01)

The Case: Chronic Kidney Disease Unmasked by Single-Subject Research
by: Benjamin Gollasch, et al.
Published: (2018-05-01)

Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study
by: Qing Jia, et al.
Published: (2022-08-01)

Membranous nephropathy: Treatment outline and risk stratification
by: Ziad Arabi
Published: (2012-07-01)

Association Between Variants in Calcineurin Inhibitor Pharmacokinetic and Pharmacodynamic Genes and Renal Dysfunction in Adult Heart Transplant Recipients
by: Kris Oreschak, et al.
Published: (2021-04-01)

Adriamycin-Induced Nephropathy is Robust in N and Modest in J Substrain of C57BL/6
by: Claire Bryant, et al.
Published: (2022-06-01)

Clinical manifestations of IgA nephropathy combined with thin glomerular basement membrane nephropathy in children
by: Young Ju Hwang, et al.
Published: (2013-09-01)

Identification and mutational analyses of phosphorylation sites of the calcineurin-binding protein CbpA and the identification of domains required for calcineurin binding in Aspergillus fumigatus
by: Praveen Rao Juvvadi, et al.
Published: (2015-03-01)

Retrospective analysis of infections prevalence in patients with progressive systemic sclerosis treated with cyclophosphamide
by: Małgorzata Schlabs, et al.
Published: (2015-09-01)

Cloning and Functional Analysis of Calcineurin Subunits A and B in Development and Fecundity of Nilaparvata lugens (Stål)
by: Wang Weixia, et al.
Published: (2022-03-01)

IgM nephropathy; can we still ignore it
by: Aruna Vanikar
Published: (2013-04-01)

Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
by: Cahyani Gita Ambarsari, et al.
Published: (2023-07-01)

Calcineurin
by: Trevor P. Creamer
Published: (2020-08-01)

Comparing the Efficacy of Monthly Cyclophosphamide as Monotherapy versus Daily Fingolimod in Relapsing Remitting and Secondary Progressive Multiple Sclerosis
by: Vahid Shaygannezhad, et al.
Published: (2017-08-01)

Chemometric modeling of different types of electrochemical data for investigation of the binding and inhibition of calcineurin by cyclosporine
by: Ali R. Jalalvand
Published: (2020-08-01)

Chemometrics assisted-electrochemical investigation of the binding and inhibition of calcineurin by tacrolimus: A combinatorial study
by: Ali R. Jalalvand
Published: (2021-12-01)

Efficacy of extracorporeal plasma therapy for adult native kidney patients with Primary FSGS: a Systematic review
by: Jing Miao, et al.
Published: (2023-12-01)

Tip Lesion Most Frequent FSGS Variant Related to COVID-19 Vaccine: Two Case Reports and Literature Review
by: Emmy Marjorie Carvalho de Araújo, et al.
Published: (2024-01-01)

The relationship between serum uric acid levels and glomerular ischemic lesions in patients with Immunoglobin A nephropathy-a analytical cross-sectional study
by: Bolong Fang, et al.
Published: (2022-07-01)